Salts of potassium ATP channel openers and uses thereof

Details Salts of potassium ATP channel openers and uses thereof Salts of potassium ATP channel openers and uses thereof

2009-02-24

2009-08-11

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S012000

Reexamination Certificate

active

07572789

ABSTRACT:
Provided are immediate or prolonged administration of certain salts of KATPchannel openers such as diazoxide to a subject to achieve novel pharmacodynamic, pharmacokinetic, therapeutic, physiological, metabolic and compositional outcomes in the treatment of diseases or conditions involving KATPchannels. Also provided are pharmaceutical formulations, methods of administration and dosing of the salts that achieve these outcomes and reduce the incidence of adverse effects in treated individuals. Further provided are method of co-administering the salts with other drugs to treat diseases of humans and animals.

REFERENCES:
patent: 2678311 (1954-05-01), Delmar et al.
patent: 2986573 (1961-05-01), Topliss et al.
patent: 3265573 (1966-08-01), Goldberg
patent: 3269906 (1966-08-01), Topliss et al.
patent: 3304228 (1967-02-01), Topliss
patent: 3345365 (1967-10-01), Topliss et al.
patent: 4029780 (1977-06-01), Nishimura et al.
patent: 4184039 (1980-01-01), Soldati et al.
patent: 4880830 (1989-11-01), Rhodes et al.
patent: 5284845 (1994-02-01), Paulsen
patent: 5356775 (1994-10-01), Hebert et al.
patent: 5378704 (1995-01-01), Weller et al.
patent: 5399359 (1995-03-01), Baichwal
patent: 5415871 (1995-05-01), Pankhania et al.
patent: 5629045 (1997-05-01), Veech
patent: 5744594 (1998-04-01), Adelman et al.
patent: 6022562 (2000-02-01), Autant et al.
patent: 6197765 (2001-03-01), Vardi et al.
patent: 6197976 (2001-03-01), Harrington et al.
patent: 6225310 (2001-05-01), Nielsen et al.
patent: 6255459 (2001-07-01), Lester et al.
patent: 6309855 (2001-10-01), Duprat et al.
patent: 6313112 (2001-11-01), Busija
patent: 6329367 (2001-12-01), Hansen et al.
patent: 6361795 (2002-03-01), Kuczynski et al.
patent: 6894043 (2005-05-01), Pirotte et al.
patent: 7053180 (2006-05-01), Johnson et al.
patent: 7268130 (2007-09-01), Desos et al.
patent: 7378414 (2008-05-01), Hutchinson et al.
patent: 2002/0035106 (2002-03-01), Hansen et al.
patent: 2002/0173636 (2002-11-01), Chen
patent: 2003/0035106 (2003-02-01), Yeh al.
patent: 2004/0097492 (2004-05-01), Pratt et al.
patent: 2004/0167123 (2004-08-01), Pratt et al.
patent: 2004/0204472 (2004-10-01), Briggs et al.
patent: 2004/0229803 (2004-11-01), Stephenson et al.
patent: 2004/0266822 (2004-12-01), Wang et al.
patent: 2005/0075331 (2005-04-01), Pratt et al.
patent: 2005/0089473 (2005-04-01), Black et al.
patent: 2005/0203072 (2005-11-01), Rudolph et al.
patent: 2006/0051418 (2006-03-01), Cowen et al.
patent: 2006/0148037 (2006-07-01), Johnson et al.
patent: 2006/0263805 (2006-11-01), Terzic et al.
patent: 2007/0191351 (2007-08-01), Cowen et al.
patent: 2007/0254863 (2007-11-01), Antel et al.
patent: 2007/0254871 (2007-11-01), Gehenne et al.
patent: 2757925 (1979-06-01), None
patent: 0 327 263 (1989-08-01), None
patent: 0 618 209 (1994-05-01), None
patent: 982072 (1961-03-01), None
patent: 59-95212 (1984-06-01), None
patent: WO 93/21171 (1993-10-01), None
patent: WO 98/10786 (1998-03-01), None
patent: WO 02/50085 (2002-06-01), None
patent: WO 03/099801 (2003-12-01), None
patent: WO 03/103606 (2003-12-01), None
patent: WO 03/105896 (2003-12-01), None
patent: WO 2004/099217 (2004-11-01), None
patent: WO 2006/000607 (2006-05-01), None
patent: WO 2006/045799 (2006-05-01), None
patent: WO 2007/081521 (2007-07-01), None
Berge “Pharmaceutical salts” J. Pharm. Sciences v.66(1) p. 1-19 (1977).
Delmar et al. “Theophylline salts” CA49:32579 (1955).
Cowen et al “salts of potassium ATP . . . ” CA 150:114355 (2009).
Calesnick et al., “Importance of Dissolution Rates in Producing Effective Diazoxide Blood Levels in Man”,Journal of Pharmaceutical Sciences, 1965, vol. 54, No. 7, pp. 1277-1280.
Chernykh et al., “Synthesis and Properties of 3-substituted 2H-1,2,4-Benzothiadiazine 1,1 Dioxide”,Khimiya Geterotsiklicheskikh Soedineii(Chemistry of Heterocyclic Compounds), 1976, vol. 4, pp. 479-483. (English Translation provided).
Drogovoz et al., “Relation Between the Structure and Diuretic Activity of 2H-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic Acid Derivatives”,Farmzkologiya I Toksikologiya(Pharmacology&Toxicology), 1977, vol. 40, No. 1, pp. 73-76. (English Translation provided).
Loubatiérés et al., “Etude Expérimentale d'un Sulfamide Hyperglycéemiant, le Diazoxide (Experimental Study of Diazoxide, a Hyperglycemic Sulfonamide”Societe de Biologie, Jan. 17, 1996, vol. 160, pp. 165-168. (English Translation provided).
Petyunin et al., “Use of 2-Sulphamoyl Oxanilic Acid Esters as a Basis for the Synthesis of Derivatives of 2-H-1,2,3-Benzothiadiazine-1,1-dioxo-3-carboxylic acid Derivatives”,Khimiya Geterotsiklicheskikh Soedineii(Chemistry of Heterocyclic Compounds),Report LVII from Heterocyclic Chemistry Research series, 1976, vol. 8, pp. 1056-1059. (English Translation provided).
Pruitt et al., “Metabolism of Diazoxide in Man and Experimental Analysis”,Journal of Pharmacology and Experimental Therapeutics, 1974, vol. 188, No. 1, pp. 248-256.
Raffa et al., “1,2,4-Benzothiadiazine Derivatives Research. Note XIII. Reaction Between 3-chloroalkyl-1,2,4-benzothiadiazine , 1-dioxide and Amines,”Farmaco Edizione Scientifica, 1960, vol. 15, pp. 700-715. (English Translation provided).
Raffa et al., “1,2,4-Benzothiadiazine Derivatives Research, Note XIV. Relation Between Chemistry and Flavor”,Farmaco Edizione Scientifica, 1960, vol. 15, pp. 716-725. (English Translation provided).
Raffa et al., “1,2,4-Benzothiadiazine Derivatives Research: Note XV. Relation Between 3-chloroalkyl-1,2,4-benzothiadiazine 1,1-dioxide and Tertiary Amines”,Farmaco Edizione Scientifica, 1960, vol. 15, pp. 845-855. (English Translation provided).
Supuran et al., “Complexes with Biologically Active Ligands. Part 1. Synthesis of Coordination Compounds of Diazoxide with Transition- and Main-group Cations”,Metal Based Drugs, 1996, vol. 3, No. 1, pp. 25-30.
Tait et al., “1,2,4-Benzothiadiazine Derivatives as α1and 5-HT1AReceptor Ligands,”Bioorganic&Medicinal Chemistry Letters, 2005, vol. 15, No. 4, pp. 1185-1188.
Aishima et al., “Actions of ZD0947, a Novel ATP-sensitive K+ Channel Opener, on Membrane Currents in Human Detrusor Myocytes”,British Journal of Pharmacology, Nov. 2006, vol. 149, No. 5, pp. 542-550.
Aizawa et al., “Prophylaxis of Genetically Determined Diabetes by Diazoxide: A Study in a Rat Model of Naturally Occurring Obese Diabetes”,J of Pharma Exp Therapy, 1995, vol. 275, No. 1, pp. 194-199.
Alemzadeh et al., “Modification of Insulin Resistance by Diazoxide in Obese Zucker Rats”,Endocrinology, 1993, vol. 133, pp. 705-712.
Alemzadeh et al., “Antiobesity Effect of Diazoxide in Obese Zucker Rats”,Metabolism, 1996, vol. 45, No. 3, pp. 334-341.
Alemzadeh et al., “Beneficial Effect of Diazoxide in Obese Hyperinsulinemic Adults”,J Clin Endocr Metab., 1998, vol. 83, pp. 1911-1915.
Alemzadeh et al., “Effect of Diazoxide on Brain Capillary Insulin Reeptor Binding and Food Intake in Hyperphagic Obese Zucker Rats”,Endocrinology, 1999, vol. 140, pp. 3197-3202.
Alemzadeh et al., “Chronic Suppression of Insulin by Diazoxide Alters the Activities of Key Enzymes Regulating Hepatic Gluconeogenesis in Zucker Rats”,Endocrinology, 2002, vol. 146, pp. 871-879.
Alemzadeh et al., “Diazoxide Enhances Adipose Tissue Protein Kinase B Activation and Glucose Transporter-4 Expression in Obese Zucker Rats”,Med Sci Monit, 2004, vol. 10, No. 3, pp. BR53-60.
Alemzadeh et al., “Modulation of Adipoinsular Axis in Prediabetic Zucker Diabetic Fatty Rats by Diazoxide”,Endocrinology, 2004, vol. 145, No. 12, pp. 5476-5484.
Babenko et al., “A View of SUR/KIR6.X, KATPChannels”,Annu. Rev. Physiol., 1998, vol. 60, pp. 667-687.
Babenko et al., “Pharmaco-topology of Sulfonylurea Receptors, Separate Domains of the Regulatory Subunits of KATPChannel Isoforms are Required for Select

Affiliated with

Also associated with

Rating

Salts of potassium ATP channel openers and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Salts of potassium ATP channel openers and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salts of potassium ATP channel openers and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4118653